Delivery Order SPE2DB20D2001-SPE2DB24FM73X
Award Date
7/11/24
Potential Completion Date
7/12/24
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB24D1104|SPE2DB25FXWD7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,858.54, is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, identified as SPE2DB20D3104|SPE2DB25FV4L4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,997.50 firm fixed-price delivery order is for the supply of 4566845521 VYVANSE 30 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB20D1004|SPE2DB23FG5Y3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.94 firm fixed-price delivery order is for the supply of 4562234183 VYVANSE 20 MG CAPSULE 100S medication. The contract has a completion date of September 20, 2023 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,129.72 Firm Fixed Price delivery order contract is for the provision of 4566831562 VYVANSE 20 MG CAPSULE 100S, with an ultimate completion date of December 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,902.66 Firm Fixed Price delivery order is for the supply of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, identified as SPE2DB20D3505|SPE2DB25FU1Y8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567604164 VYVANSE 60 MG CAPSULE 100S, a prescription medication, with a ceiling value of $1,337.70 and a performance period through March 18, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, with the ID SPE2DB24D1034|SPE2DB25FWAY4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is valued at $4,917.30 and has an ultimate completion date of March 6, 2025. The contract is for the supply of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product, and does not have a set-aside...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB25FZ20U, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,784.96, is a delivery order for the supply of 4566529414 - VYVANSE 10 MG CAPSULE 100S. The contract has a firm fixed price and an ultimate completion date of November 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,058.66 Firm Fixed Price Delivery Order contract is for the supply of VYVANSE 20 MG CAPSULE 100S, with a period of performance through March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award, with ID SPE2DB20D3505|SPE2DB23FU7A5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,760.10 delivery order contract is for the supply of 4562103055 VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price and runs through September 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company...